We are live on
!
Find out more
GCM
Gables Capital Management Portfolio holdings
AUM
$236M
1-Year Est. Return
32.91%
This Fund
S&P 500
This Quarter
Est. Return
+10.48%
1 Year Est. Return
+32.91%
3 Year Est. Return
+123.38%
5 Year Est. Return
+165.74%
10 Year Est. Return
–
AUM
$233M
AUM Growth
+$21.8M
(+10%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
38.9%
Holding
464
New
21
Increased
37
Reduced
69
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.24M |
| 2 |
CRWV
CoreWeave
CRWV
|
+$864K |
| 3 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$543K |
| 4 |
JPMorgan Chase
JPM
|
+$479K |
| 5 |
Netflix
NFLX
|
+$458K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$276K |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$196K |
| 3 |
NVIDIA
NVDA
|
+$192K |
| 4 |
Meta Platforms (Facebook)
META
|
+$143K |
| 5 |
Pfizer
PFE
|
+$127K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.3% |
| 2 | Financials | 11.12% |
| 3 | Industrials | 10.8% |
| 4 | Healthcare | 9.03% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Fortrea Holdings
FTRE
$1.75B
| $84 | ﹤0.01% |
10
| – | – |
|
452
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $79 | ﹤0.01% |
1
| – | – |
|
|
ACB
453
Aurora Cannabis
ACB
$185M
| $72 | ﹤0.01% |
12
| – | – |
|
454
UTStarcom
UTSI
$23.7M
| $64 | ﹤0.01% |
25
| – | – |
|
455
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $48 | ﹤0.01% |
1
| – | – |
|
|
AEF
456
abrdn Emerging Markets Equity Income Fund
AEF
$367M
| $39 | ﹤0.01% |
6
| – | – |
|
457
Lexaria Bioscience
LEXX
$8.71M
| $12 | ﹤0.01% |
1
| – | – |
|
|
XXII
458
22nd Century Group
XXII
$1.48M
| – | – |
0
| – | – |
|
459
Air Products & Chemicals
APD
$67.6B
| – | – |
-300
| Closed | -$84.6K |
|
460
Alexandria Real Estate Equities
ARE
$8.56B
| – | – |
-190
| Closed | -$13.8K |
|
461
Becton Dickinson
BDX
$48.7B
| – | – |
-200
| Closed | -$34.5K |
|
|
FPI
462
Farmland Partners
FPI
$432M
| – | – |
-3,500
| Closed | -$40.3K |
|
|
WBA
463
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-17,100
| Closed | -$196K |
|
|
SNRE
464
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| – | – |
-248
| Closed | -$14K |
|
Similar funds
CWL
TCM
PVM
JRPCML
CF
BCM
FCMI
FL
Gables Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Gables Capital Management held 464 positions worth $233M, up 10% from $212M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Gables Capital Management's Q3 2025 filing shows 21 new, 37 increased, 69 reduced and 6 closed positions. Its largest new stake was CoreWeave: 7,300 shares worth $999K. The largest sale was Palantir, an estimated $276K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Gables Capital Management's largest Q3 2025 buy was CoreWeave: 7,300 shares worth $999K.
- Gables Capital Management added most to Thermo Fisher Scientific in Q3 2025, an estimated $1.24M increase.
- Gables Capital Management's biggest Q3 2025 reduction was Palantir, cutting an estimated $276K.
- Gables Capital Management fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $196K.
- Gables Capital Management's ten largest holdings make up 39% of its $233M portfolio in Q3 2025.
- Gables Capital Management opened 21 new positions and closed 6 in Q3 2025.
- Gables Capital Management's portfolio value rose 10% quarter-over-quarter to $233M.
Based on Gables Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.